Metraipolis › archive › dc_54d2087ecc73

Immunotoxin WPD101a as a Potential Drug Candidate for Targeted Therapy in Muscle Invasive Bladder Cancer Expressing IL-13Rα2-In Vitro Study — Europe PMC PMID:42353280

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42353280
DOI
10.3390/ijms27125566
License (as archived)
solo-consultazione
Archived
2026-10-19T07:40:16.480Z
SHA-256 of the archived text
5968798fccdd8c350026cf9ffa3a59e50687294a006ff465b884951f8913d4fb
Stable URL of this page
https://metraipolis.com/documento/dc_54d2087ecc73

How to cite

Immunotoxin WPD101a as a Potential Drug Candidate for Targeted Therapy in Muscle Invasive Bladder Cancer Expressing IL-13Rα2-In Vitro Study — Europe PMC PMID:42353280 — Europe PMC (en), https://europepmc.org/article/MED/42353280 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_54d2087ecc73 (Metraipolis archive dc_54d2087ecc73, sha256 5968798fccdd8c350026cf9ffa3a59e50687294a006ff465b884951f8913d4fb)
BibTeX
@misc{dc54d2087ecc73,
  title = {Immunotoxin WPD101a as a Potential Drug Candidate for Targeted Therapy in Muscle Invasive Bladder Cancer Expressing IL-13Rα2-In Vitro Study — Europe PMC PMID:42353280},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42353280},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_54d2087ecc73; sha256 5968798fccdd8c350026cf9ffa3a59e50687294a006ff465b884951f8913d4fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42353280. Agents can read the archived copy with the MCP tool read_document.